NDC 63323-280-01 - Furosemide
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 63323-280
- Requested NDC
- 63323-280-01
- Package NDCs from labels
- 63323-280-01, 63323-280-02, 63323-280-03, 63323-280-04, 63323-280-05, 63323-280-10, 63323-280-41, 63323-280-16, 63323-280-43, 63323-280-26, 63323-280-45, 63323-280-36
- Manufacturer
- Cardinal Health 107, LLC
- Effective date
- 2026-10-26
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Furosemide - Cardinal Health 107, LLC | Cardinal Health 107, LLC | 2026-10-26 | HUMAN PRESCRIPTION DRUG LABEL |
| Furosemide - Cardinal Health 107, LLC | Cardinal Health 107, LLC | 2026-06-02 | HUMAN PRESCRIPTION DRUG LABEL |
| Furosemide - Fresenius Kabi USA, LLC | Fresenius Kabi USA, LLC | 2024-12-09 | HUMAN PRESCRIPTION DRUG LABEL |
| Furosemide - Fresenius Kabi USA, LLC | Fresenius Kabi USA, LLC | 2024-12-09 | HUMAN PRESCRIPTION DRUG LABEL |
| FUROSEMIDE - HF Acquisition Co LLC, DBA HealthFirst | HF Acquisition Co LLC, DBA HealthFirst | 2024-01-28 | HUMAN PRESCRIPTION DRUG LABEL |
| FUROSEMIDE - HF Acquisition Co LLC, DBA HealthFirst | HF Acquisition Co LLC, DBA HealthFirst | 2024-01-22 | HUMAN PRESCRIPTION DRUG LABEL |
| FUROSEMIDE - HF Acquisition Co LLC, DBA HealthFirst | HF Acquisition Co LLC, DBA HealthFirst | 2021-06-28 | HUMAN PRESCRIPTION DRUG LABEL |
| Model AA-8565CV-ACT Model AA-8565CV - Aerospace Accessory Service, Inc | Aerospace Accessory Service, Inc | 2021-05-18 | MEDICAL DEVICE |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 63323-280-01 | Furosemide | 2 mL in 1 VIAL | INJECTION, SOLUTION | 2 | 6 | |
| 63323-280-02 | Furosemide | 25 in 1 TRAY | INJECTION, SOLUTION | 25 | 6 | |
| 63323-280-03 | Furosemide | 4 mL in 1 VIAL | INJECTION, SOLUTION | 4 | 6 | |
| 63323-280-04 | Furosemide | 25 in 1 TRAY | INJECTION, SOLUTION | 25 | 6 | |
| 63323-280-05 | Furosemide | 10 mL in 1 VIAL | INJECTION, SOLUTION | 10 | 6 | |
| 63323-280-10 | Furosemide | 25 in 1 TRAY | INJECTION, SOLUTION | 25 | 6 | |
| 63323-280-16 | Furosemide | 25 in 1 TRAY | INJECTION, SOLUTION | 25 | 5 | |
| 63323-280-26 | Furosemide | 25 in 1 TRAY | INJECTION, SOLUTION | 25 | 5 | |
| 63323-280-36 | Furosemide | 25 in 1 TRAY | INJECTION, SOLUTION | 25 | 5 | |
| 63323-280-41 | Furosemide | 2 mL in 1 VIAL | INJECTION, SOLUTION | 2 | 5 | |
| 63323-280-43 | Furosemide | 4 mL in 1 VIAL | INJECTION, SOLUTION | 4 | 5 | |
| 63323-280-45 | Furosemide | 10 mL in 1 VIAL | INJECTION, SOLUTION | 10 | 5 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 63323-280 | FUROSEMIDE INJECTION, SOLUTION [FRESENIUS KABI USA, LLC] | 6 | Current NDC, Legacy NDC, 6 package rows | 20241222_c794c95a-654e-48fe-9596-201fc122ff75.zip |
| 63323-280 | FUROSEMIDE INJECTION, SOLUTION [FRESENIUS KABI USA, LLC] | 5 | Current NDC, Legacy NDC, 6 package rows | 20241222_3747bbcd-783d-4baa-bb5b-b6827bf390e3.zip |
DailyMed Billing Units#
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| FUROSEMIDE | ACTIVE INGREDIENT | 7LXU5N7ZO5 | FUROSEMIDE INJECTION, SOLUTION [APP PHARMACEUTICALS, LLC] | 1 | |
| FUROSEMIDE | ACTIVE MOIETY | 7LXU5N7ZO5 | FUROSEMIDE INJECTION, SOLUTION [APP PHARMACEUTICALS, LLC] | 1 | |
| HYDROCHLORIC ACID | INACTIVE INGREDIENT | QTT17582CB | FUROSEMIDE INJECTION, SOLUTION [APP PHARMACEUTICALS, LLC] | 1 | |
| SODIUM CHLORIDE | INACTIVE INGREDIENT | 451W47IQ8X | FUROSEMIDE INJECTION, SOLUTION [APP PHARMACEUTICALS, LLC] | 1 | |
| SODIUM HYDROXIDE | INACTIVE INGREDIENT | 55X04QC32I | FUROSEMIDE INJECTION, SOLUTION [APP PHARMACEUTICALS, LLC] | 1 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Ashley Belle Moisturizing Hand Sanitizer Aloe Cucumber Mist | ALCOHOL | My Imports USA LLC | abba3e7f-e79f-4c37-91dd-9e9aaf0a97f5 | 2026-07-15 | Warnings | 3K9958V90M |
| Ashley Belle Moisturizing Hand Sanitizer Sea Salt Air | ALCOHOL | My Imports USA LLC | cbecb4d1-d00a-439f-9d10-910b47c216ca | 2026-07-15 | Warnings | 3K9958V90M |
| BENZALKONIUM CHLORIDE | BENZALKONIUM CHLORIDE | H E B | 56a7ea90-51d6-f366-e063-6294a90a8bbd | 2026-07-15 | Warnings, Adverse reactions | F5UM2KM3W7 |
| Spectrum Hand Sanitizer Wipes | ETHYL ALCOHOL | Medline Industries, LP | 8642a2b5-b34e-5bbd-e053-2991aa0a55a0 | 2026-07-15 | Warnings | 3K9958V90M |
| Benzalkonium Chloride | BENZALKONIUM CHLORIDE | H E B | 56a8570f-caf4-627a-e063-6294a90a996f | 2026-07-15 | Warnings, Adverse reactions | F5UM2KM3W7 |
| Benzalkonium Chloride | BENZALKONIUM CHLORIDE | H E B | 56a90a3e-1831-29f8-e063-6294a90a0874 | 2026-07-15 | Warnings, Adverse reactions | F5UM2KM3W7 |
| Benzalkonium Chloride | BENZALKONIUM CHLORIDE | H E B | 56a94b9d-8b38-6bd9-e063-6294a90ad14a | 2026-07-15 | Warnings, Adverse reactions | F5UM2KM3W7 |
| Benzalkonium Chloride | BENZALKONIUM CHLORIDE | H E B | 56aa852a-2945-3ec8-e063-6394a90a4515 | 2026-07-15 | Warnings, Adverse reactions | F5UM2KM3W7 |
| Furosemide | FUROSEMIDE | REMEDYREPACK INC. | 3d312ab0-589c-427b-84da-18887244bfc9 | 2026-07-15 | Warnings, Adverse reactions | 7LXU5N7ZO5 |
| Quality Choice Effervescent Cold Relief - Plus | ASPIRIN, CHLORPHENIRAMINE MALEATE, PHENYLEPHRINE BITARTRATE | Chain Drug Marketing Association | 1f93fe6d-ee21-e323-e063-6394a90a61bf | 2026-07-15 | Warnings | R16CO5Y76E |
| Benzalkonium Chloride | BENZALKONIUM CHLORIDE | H E B | 56aad930-26cf-7f09-e063-6394a90a2a49 | 2026-07-15 | Warnings, Adverse reactions | F5UM2KM3W7 |
| Pentrexcilina Daytime | ACETAMINOPHEN, CHLORPHENIRAMINE MALEATE, PHENYLEPHRINE HCL | OPMX LLC | b7b3c15a-bb28-5c25-e053-2a95a90ad3b1 | 2026-07-15 | Warnings | 362O9ITL9D |
| Benzalkonium Chloride | BENZALKONIUM CHLORIDE | H E B | 56ab500f-83fe-f3d7-e063-6394a90a14b1 | 2026-07-15 | Warnings, Adverse reactions | F5UM2KM3W7 |
| Benzalkonium Chloride | BENZALKONIUM CHLORIDE | H E B | 56ab94e1-ef63-238a-e063-6394a90a5fdb | 2026-07-15 | Warnings, Adverse reactions | F5UM2KM3W7 |
| Quality Choice Effervescent Cold Relief - Orange | ASPIRIN, CHLORPHENIRAMINE MALEATE, PHENYLEPHRINE BITARTRATE | Chain Drug Marketing Association | 1f93c815-63c7-bfe0-e063-6394a90ab4a5 | 2026-07-15 | Warnings | R16CO5Y76E |
| Non -Alcohol Peach Scented Hand Sanitizer | BENZALKONIUM CHLORIDE | Shenzhen Lantern Scicence Co.,Ltd. | 56b26868-833c-3d72-e063-6394a90aea4f | 2026-07-15 | Warnings | M003 F5UM2KM3W7 |
| Aspirin | ASPIRIN | DOLGENCORP, LLC | 955484a6-2a7a-4b15-a9b4-e888ed5de04c | 2026-07-15 | Warnings | R16CO5Y76E |
| EPINEPHRINE | EPINEPHRINE | Fresenius Kabi USA, LLC | 4f83895f-638c-4515-af03-7c41ae60a42e | 2026-07-15 | Warnings, Adverse reactions | YKH834O4BH |
| Aspirin | ASPIRIN | Geri-Care Pharmaceuticals, Corp | 58941782-362d-4436-b365-e909bdbd29a2 | 2026-07-15 | Warnings | R16CO5Y76E |
| Yuflyma | ADALIMUMAB-AATY | CELLTRION USA, Inc. | 526d626f-8c9f-496c-b838-00a73bb36383 | 2026-07-15 | Boxed warning, Warnings, Adverse reactions | 797544 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.